Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma.

Literature DB >> 32556068

Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma.

Jason M Scovell^1,2, Karl Benz³, Iryna Samarska⁴, Taylor P Kohn³, Jody E Hooper⁴, Andres Matoso⁴, Amin S Herati³.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2020 PMID： 32556068 PMCID： PMC7303895 DOI： 10.1001/jamaoncol.2020.1641

Source DB: PubMed Journal: JAMA Oncol ISSN： 2374-2437 Impact factor: 31.777

× No keyword cloud information.

6 in total

1. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.

Authors: Kutluk Oktay; Brittany E Harvey; Ann H Partridge; Gwendolyn P Quinn; Joyce Reinecke; Hugh S Taylor; W Hamish Wallace; Erica T Wang; Alison W Loren
Journal: J Clin Oncol Date: 2018-04-05 Impact factor: 44.544

2. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.

Authors: F Stephen Hodi; Jason Chesney; Anna C Pavlick; Caroline Robert; Kenneth F Grossmann; David F McDermott; Gerald P Linette; Nicolas Meyer; Jeffrey K Giguere; Sanjiv S Agarwala; Montaser Shaheen; Marc S Ernstoff; David R Minor; April K Salama; Matthew H Taylor; Patrick A Ott; Christine Horak; Paul Gagnier; Joel Jiang; Jedd D Wolchok; Michael A Postow
Journal: Lancet Oncol Date: 2016-09-09 Impact factor: 41.316

3. Testicular biopsy score count--a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males.

Authors: S G Johnsen
Journal: Hormones Date: 1970

Review 4. Endocrine, Sexual Function, and Infertility Side Effects of Immune Checkpoint Inhibitor Therapy for Genitourinary Cancers.

Authors: Akshay Sood; Daniel Cole; Firas Abdollah; Ben Eilender; Zade Roumayah; Mustafa Deebajah; Ali Dabaja; Shaheen Alanee
Journal: Curr Urol Rep Date: 2018-07-03 Impact factor: 3.092

5. Prevalence and Predictors of Sperm Banking in Adolescents Newly Diagnosed With Cancer: Examination of Adolescent, Parent, and Provider Factors Influencing Fertility Preservation Outcomes.

Authors: James L Klosky; Fang Wang; Kathryn M Russell; Hui Zhang; Jessica S Flynn; Lu Huang; Karen Wasilewski-Masker; Wendy Landier; Marcia Leonard; Karen H Albritton; Abha A Gupta; Jacqueline Casillas; Paul Colte; William H Kutteh; Leslie R Schover
Journal: J Clin Oncol Date: 2017-10-04 Impact factor: 44.544

6. Effect of a formal oncofertility program on fertility preservation rates-first year experience.

Authors: Diana M Lopategui; Emad Ibrahim; Teodoro C Aballa; Nancy L Brackett; Raphael Yechieli; Julio C Barredo; Ranjith Ramasamy
Journal: Transl Androl Urol Date: 2018-07

6 in total

1. Effects of PD-1 blockade on ovarian follicles in a prepubertal female mouse.

Authors: Pauline C Xu; Yi Luan; Seok-Yeong Yu; Jing Xu; Donald W Coulter; So-Youn Kim
Journal: J Endocrinol Date: 2021-11-24 Impact factor: 4.286

2. Trainee-Led Quality Improvement Project to Improve Fertility Preservation Counseling for Patients With Cancer.

Authors: Laura A Sena; Ramy Sedhom; Susan Scott; Amanda Kagan; Andrew H Marple; Jenna V Canzoniero; Melinda Hsu; Syed M Qasim Hussaini; Amin S Herati; Lauren Reschke; Maria Facadio Antero; Mindy S Christianson; Adam F Binder; Allen R Chen; Ross C Donehower; Kristen A Marrone; Arjun Gupta
Journal: JCO Oncol Pract Date: 2021-09-25

6. Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma-A Real World Single-Center Analysis.

Authors: Michèle Hoffmann; Stefanie Hayoz; Berna C Özdemir
Journal: Biology (Basel) Date: 2022-03-10

6 in total

Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma.

1. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.

2. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.

3. Testicular biopsy score count--a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males.

Review 4. Endocrine, Sexual Function, and Infertility Side Effects of Immune Checkpoint Inhibitor Therapy for Genitourinary Cancers.

5. Prevalence and Predictors of Sperm Banking in Adolescents Newly Diagnosed With Cancer: Examination of Adolescent, Parent, and Provider Factors Influencing Fertility Preservation Outcomes.

6. Effect of a formal oncofertility program on fertility preservation rates-first year experience.

1. Effects of PD-1 blockade on ovarian follicles in a prepubertal female mouse.

2. Trainee-Led Quality Improvement Project to Improve Fertility Preservation Counseling for Patients With Cancer.

3. Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology.

Review 4. Immune-checkpoint inhibitors: long-term implications of toxicity.

Review 5. Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy.

6. Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma-A Real World Single-Center Analysis.